- Effectiveness of premedication and rapid desensitization in hypersensitivity to L-asparaginase
-
Yoon DH, Kang SH, Kim HS, Lee JW, Yoon JS, Chung NG, Cho B
- KMID: 2218659
- Allergy Asthma Respir Dis.
- 2015 Jul;3(4):288-293.
- doi: 10.4168/aard.2015.3.4.288
PURPOSE: L-asparaginase is a crucial chemotherapeutic agent for the treatment of acute lymphoblastic leukemia. However, hypersensitivity to L-asparaginase is common which limits its clinical use. METHODS: We performed 44 cases of... -
- CITED
-
- Close
- SHARE
-
- Close
- A Clinical Study of the Side Effects of L-Asparaginase
-
Woo CW, Lee JH, Lee KC, Kim SK
- KMID: 2278186
- Korean J Pediatr Hematol Oncol.
- 1999 Oct;6(2):298-304.
PURPOSE: We evaluated the frequency and clinical characteristics of the side effects of L-asparaginase during treatment of childrens with acute lymphoblastic leukemia (ALL) & Non-Hodgkin lymphoma (NHL). METHODS: Medical records... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Cerebral Infarction in a Child with Acute Lymphoblastic Leukemia Developed during Chemotherapy with E coli Asparaginase
-
Oh JH, Cho HS, Han SW, Park CY
- KMID: 2037445
- Korean J Pediatr Hematol Oncol.
- 2000 Oct;7(2):305-309.
E. coli L-asparaginase treatment during induction therapy in acute lymphoblastic leukemia is known to be rarely complicated by thromboembolic events. It causes deficiencies of antithrombin III, plasminogen, fibrinogen, factor... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type
-
Kim HJ, Ock CY, Kim TM, Lee SH, Lee JY, Jung SH, Cho YS, Kim M, Keam B, Kim DW, Kim IH, Heo DS
- KMID: 2417856
- Cancer Res Treat.
- 2018 Jul;50(3):670-680.
- doi: 10.4143/crt.2017.051
PURPOSE: The aim of this study was to compare asparaginase-related toxicities in two asparaginase preparations, namely native Escherichia coli L-asparaginase (L-ASP) and pegylated asparaginase (PEG-ASP) in combination with ifosfamide, methotrexate,... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of L-asparaginase Related Adverse Reaction
-
Ko KM, La HO
- KMID: 2405668
- Korean J Clin Pharm.
- 2017 Sep;27(3):143-149.
- doi: 10.24304/kjcp.2017.27.3.143
OBJECTIVE: L-asparaginase (L-ASP) is a critical agent for the treatment of acute lymphoblastic leukemia and lymphoma, which is associated with serious toxicities including hypersensitivity, pancreatitis and thrombosis. METHODS: To evaluate the... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Oligodendroglioma after Treatment of Acute Lymphoblastic Leukemia in Childhood
-
Shin SH, Chung BH, Bauer S, Lee JH, Lee KC
- KMID: 2049282
- Clin Pediatr Hematol Oncol.
- 2012 Oct;19(2):118-122.
Secondary brain tumors after cranial irradiation have been reported in survivors of childhood acute lymphoblastic leukemia (ALL). We report a case of secondary oligodendroglioma, occurring in a 19-year-old male, 12... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Outcome of Adult Acute Lymphocytic Leukemia with VPD (L) Regimen: analysis of Prognostic Factors
-
Park SR, Kim JH, Kim DY, Lee SH, Lee SY, Choi IS, Yoon SS, Park SY, Kim BG, Kim NK
- KMID: 759630
- Korean J Intern Med.
- 2003 Mar;18(1):21-28.
BACKGROUND: Because of the relative paucity of data regarding the clinical outcome in adult patients with acute lymphocytic leukemia (ALL) in Korea, we analyzed clinical courses in adult ALL patients... -
- CITED
-
- Close
- SHARE
-
- Close
